Sean Emory, Founder and CIO of Avory & Co., discusses Oura's planned IPO and argues it signals the accelerating consumerization of healthcare. He highlights Oura's scale and financials, $1.2B in revenue, 74% growth, GAAP profitability, 5M paying subscribers, and 3.6M rings sold in the past 12 months, while emphasizing the story is bigger than "the next Fitbit."
He frames the shift as driven by cheaper and smaller sensors, consumers paying more directly for health through higher deductibles, GLP-1s, and cash-pay services, and AI making health data more usable. Using Oura's S-1 cohort data (72% women, 73% age 45 or younger, 63% earning $100K or more, over half with a chronic condition), he explains why Oura won by targeting finger-based wearables, improving signal quality and wear time, and pairing hardware with subscriptions. He runs Oura lightly through Avory's 6M framework and flags retention and churn as the key unknown until more cohort data is public.
Chapters
00:00 Oura IPO Snapshot
01:10 Channel Intro and Approach
02:03 Why Oura Matters Now
03:56 Big Tech Health Moves
04:51 Three Forces Driving Change
07:04 Who Uses Oura
09:56 Winning the Finger
13:31 Subscription and Engagement Loop
16:06 6M Investor Lens
19:59 What Comes Next
More from Avory & Co.
Newsletter (Investing with Data):
www.investingwithdata.com
Website: avoryfunds.com
Informational only. Not personal investment advice. Opinions reflect Avory & Co.'s views as of the recording date and may change. Avory & Co. and Sean Emory may hold positions in securities discussed. Do your own research and consult your financial professional before making investment decisions.
